1. Abrams P, Artibani W, Cardozo L, Dmochowski R, van Kerrebroeck P, Sand P. International Continence Society. Reviewing the ICS 2002 terminology report: the ongoing debate. Neurourol Urodyn. 2009; 28:287. PMID:
19350662.
Article
2. Milsom I, Kaplan SA, Coyne KS, Sexton CC, Kopp ZS. Effect of bothersome overactive bladder symptoms on health-related quality of life, anxiety, depression, and treatment seeking in the United States: results from EpiLUTS. Urology. 2012; 80:90–96. PMID:
22748867.
Article
3. Sexton CC, Coyne KS, Kopp ZS, Irwin DE, Milsom I, Aiyer LP, et al. EpiLUTS Team. The overlap of storage, voiding and post-micturition symptoms and implications for treatment seeking in the USA, UK and Sweden: EpiLUTS. BJU Int. 2009; 103(Suppl 3):12–23. PMID:
19302498.
Article
4. Irwin DE, Milsom I, Chancellor MB, Kopp Z, Guan Z. Dynamic progression of overactive bladder and urinary incontinence symptoms: a systematic review. Eur Urol. 2010; 58:532–543. PMID:
20573443.
Article
5. Carmeli E, Patish H, Coleman R. The aging hand. J Gerontol A Biol Sci Med Sci. 2003; 58:146–152. PMID:
12586852.
Article
6. White-Chu EF, Reddy M. Dry skin in the elderly: complexities of a common problem. Clin Dermatol. 2011; 29:37–42. PMID:
21146730.
Article
7. Faul F, Erdfelder E, Lang AG, Buchner A. G
*Power 3: a flexible statistical power analysis program for the social, behavioral, and biomedical sciences. Behav Res Methods. 2007; 39:175–191. PMID:
17695343.
8. Irwin DE, Milsom I, Hunskaar S, Reilly K, Kopp Z, Herschorn S, et al. Population-based survey of urinary incontinence, overactive bladder, and other lower urinary tract symptoms in five countries: results of the EPIC study. Eur Urol. 2006; 50:1306–1314. PMID:
17049716.
Article
9. Huh JS, Kim YJ, Kim SD. Prevalence of benign prostatic hyperplasia on Jeju Island: analysis from a cross-sectional community-based survey. World J Mens Health. 2012; 30:131–137. PMID:
23596600.
Article
10. Choi HC, Kwon JK, Lee JY, Han JH, Jung HD, Cho KS. Seasonal variation of urinary symptoms in korean men with lower urinary tract symptoms and benign prostatic hyperplasia. World J Mens Health. 2015; 33:81–87. PMID:
26331124.
Article
11. Coyne KS, Sexton CC, Bell JA, Thompson CL, Dmochowski R, Bavendam T, et al. The prevalence of lower urinary tract symptoms (LUTS) and overactive bladder (OAB) by racial/ethnic group and age: results from OAB-POLL. Neurourol Urodyn. 2013; 32:230–237. PMID:
22847394.
Article
12. Stewart WF, Van Rooyen JB, Cundiff GW, Abrams P, Herzog AR, Corey R, et al. Prevalence and burden of overactive bladder in the United States. World J Urol. 2003; 20:327–336. PMID:
12811491.
Article
13. Heidler S, Mert C, Temml C, Madersbacher S. The natural history of the overactive bladder syndrome in females: a long-term analysis of a health screening project. Neurourol Urodyn. 2011; 30:1437–1441. PMID:
21661037.
Article